Wataru Yamamoto

Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis

Mie Torii, Motomu Hashimoto, Akiko Hanai et al. · Modern Rheumatology · 2018 · 165 citations

Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study-

Kosuke Ebina, Motomu Hashimoto, Wataru Yamamoto et al. · PLoS ONE · 2018 · 118 citations · Full text

Disease Activity Score, Pharmacotherapy, Inflammatory Arthritis +16

Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer

Ken‐ichi Fujita, Wataru Yamamoto, Toshimichi Miya et al. · Cancer Chemotherapy and Pharmacology · 2009 · 102 citations

Oncogenic Agent, Medicine, Pharmacology +9

Pharmacogenetic impact of polymorphisms in the coding region of the <i>UGT1A1</i> gene on SN‐38 glucuronidation in Japanese patients with cancer

Kazuhiro Araki, Ken‐ichi Fujita, Fumio Nagashima et al. · Cancer Science · 2006 · 91 citations · Full text

Central nervous system event in patients with diffuse large B‐cell lymphoma in the rituximab era

Naoto Tomita, Masahiro Yokoyama, Wataru Yamamoto et al. · Cancer Science · 2011 · 88 citations

Neuro-oncology, Lymphoid Neoplasia, Medicine +6